AstraZeneca (AZN) F-3ASR Automatic shelf registration (foreign)

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors
AstraZeneca PLC:

We consent to the use of our reports dated February 4, 2016, with respect to the consolidated statements of financial position of AstraZeneca PLC and subsidiaries as of December 31, 2015 and 2014, and the related consolidated statements of comprehensive income, changes in equity, and cash flows for each of the years then ended, and the effectiveness of internal control over financial reporting as of December 31, 2015, incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.

/s/ KPMG LLP

London, United Kingdom
November 22, 2016